Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer

Journal of the National Cancer Institute
Susan J RamusSimon A Gayther

Abstract

Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy, responsible for 13 000 deaths per year in the United States. Risk prediction based on identifying germline mutations in ovarian cancer susceptibility genes could have a clinically significant impact on reducing disease mortality. Next generation sequencing was used to identify germline mutations in the coding regions of four candidate susceptibility genes-BRIP1, BARD1, PALB2 and NBN-in 3236 invasive EOC case patients and 3431 control patients of European origin, and in 2000 unaffected high-risk women from a clinical screening trial of ovarian cancer (UKFOCSS). For each gene, we estimated the prevalence and EOC risks and evaluated associations between germline variant status and clinical and epidemiological risk factor information. All statistical tests were two-sided. We found an increased frequency of deleterious mutations in BRIP1 in case patients (0.9%) and in the UKFOCSS participants (0.6%) compared with control patients (0.09%) (P = 1 x 10(-4) and 8 x 10(-4), respectively), but no differences for BARD1 (P = .39), NBN1 ( P = .61), or PALB2 (P = .08). There was also a difference in the frequency of rare missense variants in BRIP1 between case patien...Continue Reading

References

Jan 1, 1988·Genetic Epidemiology·K LangeM Boehnke
Nov 1, 1996·Nature Genetics·S MazoyerG M Lenoir
Feb 15, 2001·American Journal of Human Genetics·D ThompsonUNKNOWN Breast Cancer Linkage Consortium
Oct 25, 2003·Science·Xiaochun YuJunjie Chen
Apr 10, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sunil R LakhaniDouglas F Easton
May 20, 2009·Bioinformatics·Heng Li, Richard Durbin
Jul 6, 2010·Nucleic Acids Research·Kai WangHakon Hakonarson
Sep 21, 2010·Nature Genetics·Kelly L BoltonSimon A Gayther
Sep 28, 2010·Nature Structural & Molecular Biology·Rémi BuissonJean-Yves Masson
Jan 12, 2011·Nature Biotechnology·James T RobinsonJill P Mesirov
Aug 9, 2011·Nature Genetics·Chey LovedayNazneen Rahman
Oct 4, 2011·Nature Genetics·Thorunn RafnarKari Stefansson
Oct 19, 2011·Proceedings of the National Academy of Sciences of the United States of America·Tom WalshElizabeth M Swisher
Apr 28, 2012·Nature Genetics·Chey LovedayNazneen Rahman
Dec 6, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adam N RosenthalIan J Jacobs
Mar 29, 2013·Nature Communications·Jennifer Permuth-WeySimon A Gayther
Mar 29, 2013·Nature Genetics·Paul D P PharoahThomas A Sellers
Aug 8, 2014·The New England Journal of Medicine·Antonis C AntoniouMarc Tischkowitz
Jan 13, 2015·Nature Genetics·Karoline B KuchenbaeckerUNKNOWN Consortium of Investigators of Modifiers of BRCA1 and BRCA2

❮ Previous
Next ❯

Citations

Aug 16, 2016·European Journal of Human Genetics : EJHG·Dominique Stoppa-Lyonnet
Nov 3, 2016·Breast Cancer Research and Treatment·Ciyu YangLiying Zhang
Feb 9, 2017·Clinical Case Reports·Jennifer GassPaldeep S Atwal
Feb 12, 2017·F1000Research·Kathryn Mills, Katherine Fuh
Apr 14, 2017·Diagnostics·Edward J Pavlik
Feb 2, 2018·Wellcome Open Research·Jean-Yves BleuyardFumiko Esashi
Apr 18, 2018·Journal of Medical Genetics·Amy TaylorUNKNOWN UK Cancer Genetics Group (UK-CGG)
May 29, 2018·CA: a Cancer Journal for Clinicians·Lindsey A TorreRebecca L Siegel
Mar 2, 2019·Cancer Biology & Therapy·Joanna Moes-SosnowskaJolanta Kupryjanczyk
Feb 13, 2019·MDM Policy & Practice·Lars Asphaug, Hans Olav Melberg
May 18, 2019·Clinical Genetics·Nicola FlaumDafydd G Evans
Aug 31, 2019·Scientific Reports·Thilo DörkDouglas F Easton
Oct 2, 2019·International Journal of Molecular Medicine·Mikael Kronborg ChristophersenEstrid Høgdall
Feb 11, 2020·Frontiers in Oncology·Cecilie AbildgaardSilvia R Rogatto
Feb 13, 2020·International Journal of Molecular Sciences·Davide AngeliGianluca Tedaldi
Aug 18, 2020·BJOG : an International Journal of Obstetrics and Gynaecology·F GabaR Manchanda
Oct 1, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alessandro MannucciSapna Syngal
Mar 16, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nadine TungJudy E Garber
Aug 16, 2016·Nature Reviews. Cancer·Finn Cilius NielsenClaus Storgaard Sørensen
Sep 16, 2016·Familial Cancer·Joanne KotsopoulosMohammad R Akbari
Aug 31, 2016·Archives of Pathology & Laboratory Medicine·Brandon S SheffieldKasmintan A Schrader
Jun 15, 2017·Breast Care·Eric HahnenRita K Schmutzler
Apr 12, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Goli SamimiMark E Sherman
Jan 3, 2018·The Journal of Pathology·Diana Mandelker, Liying Zhang
May 8, 2018·Journal of Medical Genetics·Xin YangAntonis C Antoniou
Sep 14, 2018·Cell Cycle·Srijita Dhar, Robert M Brosh
May 18, 2018·Journal of Gynecologic Oncology·Min Chul ChoiJe Ho Lee
Oct 26, 2018·British Journal of Cancer·Darren R HodgsonJ Carl Barrett
Mar 31, 2019·International Journal of Cancer. Journal International Du Cancer·Lídia FeliubadalóUNKNOWN Catalan Hereditary Cancer Group
Jul 30, 2019·Journal of Surgical Oncology·Alexandra S Bercow, Eric L Eisenhauer
Jul 28, 2019·Current Oncology Reports·Denise R NebgenRobert C Bast
Aug 14, 2019·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Susan M Domchek, Mark E Robson
May 16, 2019·Journal of Human Genetics·Andromachi VagenaFlorentia Fostira
Jul 3, 2019·International Journal of Cancer. Journal International Du Cancer·Qianqian ZhuKunle O Odunsi
Apr 2, 2020·World Journal of Gastroenterology : WJG·Ioannis A Voutsadakis
May 28, 2020·Journal of Personalized Medicine·Stergios BoussiosNicholas Pavlidis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.